Concepedia

Publication | Open Access

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

DOIFull Paper Access

182

Citations

17

References

2020

Year

Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz, Kimberly Meade‐White, Danielle Porter, Jonathan E. Schulz, Neeltje van Doremalen, Ian Leighton, Claude Kwe Yinda, Lizzette Pérez-Pérez,

Unknown Venue

Abstract

Therapeutic remdesivir treatment initiated early during infection has a clear clinical benefit in SARS-CoV-2-infected rhesus macaques. These data support early remdesivir treatment initiation in COVID-19 patients to prevent progression to severe pneumonia.

References

YearCitations

Page 1